# A Single-center, Randomized, Double-blind, Placebo-controlled, Intervention Clinical Trial to Evaluate the Efficacy and Safety of "KoreaGinseng F Max" on Blood Circulation Improvement in Adults With Poor Peripheral Blood Flow

> **NCT07643532** · NA · NOT_YET_RECRUITING · sponsor: **Haiphong University of Medicine and Pharmacy** · enrollment: 100 (estimated)

## Conditions studied

- Blood Circulation
- Peripheral Blood Flow
- Platelet Aggregation

## Interventions

- **DIETARY_SUPPLEMENT:** KoreaGinseng F Max
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07643532
- **Lead sponsor:** Haiphong University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-10
- **Primary completion:** 2026-12-10
- **Final completion:** 2028-06-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643532, "A Single-center, Randomized, Double-blind, Placebo-controlled, Intervention Clinical Trial to Evaluate the Efficacy and Safety of "KoreaGinseng F Max" on Blood Circulation Improvement in Adults With Poor Peripheral Blood Flow". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*